SEC Comment Letter 0000000000-25-000893 to Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Jan. 28, 2025 · CIK: 0001106838 · Accession: 0000000000-25-000893
AI Filing Summary & Sentiment
File numbers found in text: 333-284409
Letter
January 28, 2025 Pankaj Mohan Chief Executive Officer Sonnet BioTherapeutics Holdings, Inc. 100 Overlook Center, Suite 102 Princeton, NJ 08540 Re:Sonnet BioTherapeutics Holdings, Inc. Registration Statement on Form S-1 Filed January 22, 2025 File No. 333-284409 Dear Pankaj Mohan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Steven M. Skolnick, Esq.
Show Raw Text
January 28, 2025
Pankaj Mohan
Chief Executive Officer
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center, Suite 102
Princeton, NJ 08540
Re:Sonnet BioTherapeutics Holdings, Inc.
Registration Statement on Form S-1
Filed January 22, 2025
File No. 333-284409
Dear Pankaj Mohan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Steven M. Skolnick, Esq.